tacrolimus XR / Generic mfg. 
Welcome,         Profile    Billing    Logout  

46 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tacrolimus XR / Generic mfg.
2009-014670-17: Controlled study on the Relative Pharmacokinetics of Advagraf versus Prograft in Kidney transplant patients with severe Diarrhoea

Ongoing
4
30
Europe
Tacrolimus capsules, tacrolimus prolonged-release hard capsules, L04AA05, Capsule, hard, Prograf(t) Capsules, advagraf prolonged release hard capsules
H.-Hartziekenhuis Roeselare-Menen vzw
Renal transplant patients suffering from diarrhea
 
 
2010-021075-89: A MULTICENTER, THREE ARM, RANDOMIZED, OPEN LABEL CLINICAL STUDY TO COMPARE RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS RECEIVING AN IMMUNOSUPPRESSIVE REGIMEN OF ADVAGRAF® (IMMEDIATELY OR DELAYED POST-TRANSPLANT) AND MMF WITH OR WITHOUT A MONOCLONAL ANTI-IL2R ANTIBODY (BASILIXIMAB)

Ongoing
4
150
Europe
Capsule, hard, Powder and solvent for solution for injection, Advagraf, Simulect
Astellas Pharma Europe Ltd.
RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS RECEIVING AN IMMUNOSUPPRESSIVE REGIMEN OF ADVAGRAF® (IMMEDIATELY OR DELAYED POST-TRANSPLANT) AND MMF WITH OR WITHOUT SIMULECT
 
 
ChiCTR-ONC-10001519: Multi-center, open-label, non-controlled study of the efficacy and safety of cyclosporine switched to Tacrolimus extended release capsules in renal transplant recipients.

Completed
4
105
 
tacrolimus extended release capsules replacing cyclosporine
People's Liberation Army; Astellas Pharma (China) Co., Ltd., Astellas Pharma (China) Co., Ltd.
renal transplant recipient
 
 
2012-005652-42: Biomarker after conversion to belatacept mediaction in comparison to standard therapy in renal transplant patients.

Ongoing
4
70
Europe
Lyophilisate for solution for infusion, Capsule, hard, Tablet, Capsule, soft, Nulojix 250mg, Prograf 1 mg, Prograf 0.5 mg, Prograf 5 mg, Certican 0.1mg, Certican 0.25mg, Certican 0.5mg, Certican 0.75mg, Certican 1 mg, Sandimmun Optoral 10mg, Sandimmun Optoral 25 mg, Sandimmun Optoral 50 mg, Sandimmun Optoral 100 mg, Advagraf 0.5 mg, Advagraf 1 mg, Advagraf 3 mg, Advagraf 5 mg
Charité, Universitätsmedizin Berlin, Bristol-Myers Squibb GmbH & Co. KGaA
Patients after renal transplantation with signs of drug intolerance to their immunsuppressive therapy are considered to be converted to Nulojix, Patients after renal transplantation with signs of drug intolerance to their immunsuppressive therapy are considered to be converted to Nulojix, Not possible to specify
 
 
2013-000793-30: Development of a dosingprogram for tacrolimus in children

Not yet recruiting
4
140
Europe
Modified-release capsule, hard, Capsule, Granules for oral solution, Advagraf, Prograf, Modigraf
Oslo University Hospital - Rikshospitalet, OUS-Rikshospitalet
Solid organ transplantation, Impaired organ function, Body processes [G] - Immune system processes [G12]
 
 
2013-004538-14: Trascriptomic differences between tacrolimus and mTOR inhibitors in the immunosuppressive treatment of renal transplantation Differenze transcrittomiche tra Tacrolimus e inibitori di mTOR nel trattamento immunosoppressivo del Trapianto renale

Ongoing
4
40
Europe
FK-506, Prolonged-release capsule, Tablet, ADVAGRAF 30CPS 3MG RP, ADVAGRAF 30CPS 0,5 MG RP, ADVAGRAF 60CPS 1MG RP, CERTICAN 60 cpr 0,75 mg, CERTICAN 60 cpr 0,25 mg, RAPAMUNE 100CPR RIV 1MG, RAPAMUNE 30CPR RIV 2MG, MYCOPHENOLATE MOFETIL 50CPR 500MG
Azienda Ospedaliera Universitaria Integrata Verona, Università di Verona
Renal Transplantation Trapianto renale, Renal Transplantation Trapianto renale, Not possible to specify
 
 
2007-005410-39: “Estudio piloto aleatorizado comparativo de tacrolimus vs ciclofosfamida-prednisona en la nefropatía membranosa idiopática”

Ongoing
4
40
Europe
Advagraf 0,5mg, Genoxal, Dacortín 2,5mg, Advagraf 1mg, Advagraf 5mg, Dacortín 5mg, Dacortín 30mg, Advagraf 0,5mg, Genoxal, Dacortín 2,5mg, Advagraf 1mg, Advagraf 5mg, Dacortín 5mg, Dacortín 30mg
Grupo Catalán de Estudio de enfermedades glomerulares. Sociedad Catalana de nefrología.
La nefropatía membranosa idiopática (NMI) es una enfermedad caracterizada histopatológicamente por un engrosamiento uniforme de la pared de los capilares glomerulares, debido al depósito de complejos inmunes a lo largo del espacio subepitelial, en ausencia de inflamación o cambios proliferativos en el resto del glomérulo. El origen exacto de este trastorno se desconoce sin embargo se sabe que la NMI es una causa frecuente de síndrome nefrótico (SN) del adulto.
 
 
2009-014050-15: Conversion from a twice-daily tacrolimus (tac) regimen to a once-daily tacorlimus exended-release formulation (TacXL) regimen : Pharamcokinetic studies in stable cystic fibrosis (CF) and non-CF patients having received a pulmonary transplant

Ongoing
4
20
Europe
Tacrolimus capsules, Tacrolimus prolonged-release hard capsules, Prograft capsules, Advagraf prolonged-release hard capsules, Prograft capsules, Advagraf prolonged-release hard capsules
Hopital Erasme - Chest service
Stable cystic fibrosis (CF) and non-CF patients having received a pulmonary transplant
 
 
2009-013461-25: The influence of CYP3A5 and ABCB1 genotype on the pharmacokinetics of twice daily Tacrolimus and Advagraf

Ongoing
4
330
Europe
Prograf 0.5, 1 and 5 mg, Advagraf 0.5, 1, 3 and 5mg, Prograf, Advagraf, Prograf, Advagraf
St. George\'s, University of London, Astellas
Renal transplantation.
 
 
2010-019086-28: Multicenter, no-profit, open, single sequence cross-over study on effectiveness and safety of anti-rejection therapy based on modified release Tacrolimus(Advagraf)and on patients quality of life and adhesion to therapeutical regimen improvement after switch from conventional BID(Prograf) Tacrolimus immunosuppressive therapy to mono-administration of modified release of Tacrolimus in stable kidney transplant recipient

Ongoing
4
210
Europe
ADVAGRAF*30CPS 0,5MG R.P., ADVAGRAF*30CPS 1MG R.P., ADVAGRAF*50CPS 5MG R.P., ADVAGRAF*30CPS 0,5MG R.P., ADVAGRAF*30CPS 1MG R.P., ADVAGRAF*50CPS 5MG R.P.
UO Divisione Nefrologia, Dialisi e Trapianto renale
Kidney transplant patients
 
 
2013-000985-13: PRE-transplant pharmacokinetics and Advagraf® Dosing In kidney transplant ReCipienTs Farmacocinética pre-trasplante y dosis de Advagraf® en receptores de trasplanate renal

Ongoing
4
20
Europe
Advagraf, Advagraf
Astellas Pharma Europe Ltd., Astellas Pharma Europe Ltd.
Prophylaxis of transplant rejection in adult kidney allograft recipients. Profilaxis del rechazo del trasplante en receptores de un injerto renal
 
 
2015-002465-28: Anti-donor alloreactivity-guided CNI minimization versus unguided standard triple therapy in living-donor kidney transplantation Immunmonitoring-gestützte Minimierung einer Calcineurin-Inhibitor basierten Standard 3-fach Immunsuppression im Vergleich zu einer Medikamentenspiegel orientierten Standardimmunsuppression in der Nierenlebendspendetransplantation

Ongoing
4
100
Europe
Tacrolimus, Capsule, hard, Advagraf
Klinikum der Universität München, Astellas Pharma GmbH
Renal transplantation Nierentransplantation, Renal transplantation Nierentransplantation, Body processes [G] - Immune system processes [G12]
 
 
2016-002097-13: Use of tacrolimus in heart transplant recipients Uporaba tacrolimusa pri bolnikih po presaditvi srca

Ongoing
4
70
Europe
Capsule, Advagraf
Department of Cardiology, University Medical Centre Ljubljana, University Medical Centre Ljubljana
Tacrolimus is a potent immunosuppressant agent widely used for the prevention and treatment of rejection in heart transplant recipients. While tacrolimus is typically administered in two divided doses per day, a new oral formulation with modified-release characteristics has recently been developed and licensed for use. Specifically formulated to enable once daily dosing, it was suggested that the benefit of the prolonged-release preparation maybe improved compliance., While tacrolimus is administered in two doses per day, a new oral formulation with modified-release characteristics has recently been developed and licensed for use possibly improving compliance., Body processes [G] - Immune system processes [G12]
 
 
ChiCTR1800016648: Clinical Outcome of Delayed or Standard Prograf Together with Induction Therapy Followed by Conversion to Advagraf in DCD Kidney Transplant Recipients: A Randomized, Open-label, Multicenter Clinical Trial

Not yet recruiting
4
300
 
induction therapy + standard Prograf + conversion Advagraf ;induction therapy + delayed Prograf + conversion Advagraf
Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology; Astellas Pharma China, Inc., Pharmaceutical Enterprise
DCD kidney transplantation.
 
 
ChiCTR1900020719: To evaluate the efficacy and safety of tacrolimus extended-release capsules and tacrolimus capsules in early postoperative immunosuppression in adult DCD liver transplantation recipients: a single-center, open-label, randomized controlled trial

Recruiting
4
50
 
extended-release tacrolimus ;tacrolimus
Shulan (Hangzhou) Hospital; Shulan (Hangzhou) Hospital, Astellas Pharma China, Inc.
Liver transplantation
 
 
ReMIND, NCT01095172 / 2009-017066-23: RituxiMab INDuction in Renal Transplantation

Checkmark BTS 2016: ReMIND
Mar 2016 - Mar 2016: BTS 2016: ReMIND
Active, not recruiting
4
100
Europe
Rituximab, Mabthera, Tacrolimus, Advagraf, Adoport, Prograf, Mycophenylate mofetil, MMF, Cellcept, Hydrocortisone, Prednisolone
Guy's and St Thomas' NHS Foundation Trust, Astellas Pharma Europe Ltd.
Function of Renal Transplant
10/20
10/22
NCT03216447: A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant

Recruiting
4
150
RoW
Advagraf, Prograf
Chang Gung Memorial Hospital, Astellas Pharma Taiwan, Inc.
Liver Transplantation
08/23
09/25
NCT06147648: Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation.

Not yet recruiting
4
352
NA
Tacrolimus Sustained-release Capsules
Beijing Tsinghua Chang Gung Hospital
Liver Transplantation
07/25
07/26
ChiCTR2200063697: once-daily immunosuppressive regimen in kidney transplant recipients

Not yet recruiting
4
160
 
Tac-ER+SRL ;Tac+MPA
Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of science and technology; Level of the institution：, NO
kidney transplantation
 
 
NCT04917718: Renal Tubular Injury and Transplant Outcomes in Cardiac Recipients Converting From IR Tacrolimus to XR Tacrolimus

Recruiting
4
42
US
Conversion from IR Tacrolimus to XR Tacrolimus
Loyola University, Veloxis Pharmaceuticals
Chronic Kidney Diseases, Heart Transplant
12/24
12/24
NCT03672110 / 2013-001770-19: Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen

Active, not recruiting
3
400
Europe
Advagraf, no other intervention name
Technische Universität Dresden
Renal Failure, Renal Insufficiency, Renal Disease, Renal Insufficiency, Chronic
02/20
12/25
NCT05457556: Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome

Recruiting
3
435
Canada, US, RoW
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspiration, Busulfan, 1, 4-Bis[methanesulfonoxy]butane, BUS, Busilvex, Bussulfam, Busulfanum, Busulfex, Busulphan, CB 2041, CB-2041, Glyzophrol, GT 41, GT-41, Joacamine, Methanesulfonic Acid Tetramethylene Ester, Methanesulfonic acid, tetramethylene ester, Mielucin, Misulban, Misulfan, Mitosan, Myeleukon, Myeloleukon, Myelosan, Mylecytan, Myleran, Sulfabutin, Tetramethylene Bis(methanesulfonate), Tetramethylene bis[methanesulfonate], WR-19508, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B-518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, WR-138719, Echocardiography, EC, Fludarabine, Fluradosa, Haploidentical Hematopoietic Cell Transplantation, Haploidentical Stem Cell Transplantation, HLA-Haploidentical Hematopoietic Cell Transplantation, Stem Cell Transplantation, Haploidentical, Lapine T-Lymphocyte Immune Globulin, Anti-Thymocyte Globulin Rabbit, Antithymocyte Globulin Rabbit, Grafalon, Rabbit Anti-Human Thymocyte Globulin (RATG), Rabbit Anti-Thymocyte Globulin, Rabbit Antithymocyte Globulin, Rabbit ATG, Thymoglobulin, Lumbar Puncture, LP, Spinal Tap, Matched Unrelated Donor Hematopoietic Cell Transplantation, MUD-HCT, Melphalan, Alanine Nitrogen Mustard, CB-3025, L-PAM, L-Phenylalanine Mustard, L-Sarcolysin, L-Sarcolysin Phenylalanine mustard, L-Sarcolysine, Melphalanum, Phenylalanine Mustard, Phenylalanine Nitrogen Mustard, Sarcoclorin, Sarkolysin, WR-19813, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Mycophenolate Mofetil, CellCept, MMF, Myeloablative Conditioning, Myeloablation, Myeloablative, Myeloablative Cytoreduction, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Rituximab, ABP 798, BI 695500, C2B8 Monoclonal Antibody, Chimeric Anti-CD20 Antibody, CT-P10, IDEC-102, IDEC-C2B8, IDEC-C2B8 Monoclonal Antibody, Ikgdar, Mabtas, MabThera, Monoclonal Antibody IDEC-C2B8, PF-05280586, Riabni, Rituxan, Rituximab ABBS, Rituximab ARRX, Rituximab Biosimilar ABP 798, Rituximab Biosimilar BI 695500, Rituximab Biosimilar CT-P10, Rituximab Biosimilar GB241, Rituximab Biosimilar IBI301, Rituximab Biosimilar JHL1101, Rituximab Biosimilar PF-05280586, Rituximab Biosimilar RTXM83, Rituximab Biosimilar SAIT101, Rituximab Biosimilar SIBP-02, rituximab biosimilar TQB2303, Rituximab PVVR, Rituximab-abbs, Rituximab-arrx, Rituximab-pvvr, RTXM83, Ruxience, Truxima, T-Cell Depletion Therapy, T-Cell Depletion, T-Lymphocyte Depletion Therapy, Tacrolimus, FK 506, FK-506, Fujimycin, Hecoria, Prograf, Protopic, Tacforius, Thiotepa, 1,1',1''-Phosphinothioylidynetrisaziridine, Girostan, N,N', N''-Triethylenethiophosphoramide, Oncotiotepa, STEPA, Tepadina, TESPA, Tespamin, Tespamine, Thio-Tepa, Thiofosfamide, Thiofozil, Thiophosphamide, Thiophosphoamide, Thiophosphoramide, Thiotef, Tifosyl, TIO TEF, Tio-tef, Triethylene Thiophosphoramide, Triethylenethiophosphoramide, Tris(1-aziridinyl)phosphine sulfide, TSPA, WR 45312, Total-Body Irradiation, SCT_TBI, TBI, Total Body Irradiation, Whole Body, Whole Body Irradiation, Whole-Body Irradiation
Children's Oncology Group
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome
12/27
12/27
NCT03500848: Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation

Not yet recruiting
2/3
130
RoW
Tacrolimus, FK-506, Fujimycin, Prograf, Protopic, Advagraf, Tacrolimus (Tacrolimus elimination), Sirolimus, Rapamune, MMF and/or steroids, Mycophenolate mofetil
Southern Medical University, China, First Affiliated Hospital, Sun Yat-Sen University, Nanfang Hospital of Southern Medical University
Liver Transplantation
05/23
05/23
NCT01294020 / 2010-020925-42: Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

Active, not recruiting
2
81
Europe, RoW
Tacrolimus, Prograf, FK506, Tacrolimus prolonged release, FK506E, MR4, Advagraf, tacrolimus modified release, Astagraf XL, Graceptor, Prograf XL
Astellas Pharma Europe Ltd.
Intestine Transplantation, Kidney Transplantation, Lung Transplantation, Liver Transplantation, Heart Transplantation
10/15
05/26
2009-015863-15: ENSAYO CLÍNICO DE FASE II, ABIERTO, UNICÉNTRICO, PILOTO PARA EVALUAR LAS CARACTERÍSTICAS FARMACOCINÉTICAS, SEGURIDAD Y TOLERABILIDAD, TRAS LA CONVERSIÓN DE UN RÉGIMEN INMUNOSUPRESOR CON PROGRAF® A TACROLIMUS DE LIBERACIÓN PROLONGADA (ADVAGRAF®) EN PACIENTES CON TRASPLANTE PULMONAR ESTABLE

Ongoing
2
20
Europe
ADVAGRAF 0,5 mg cápsulas duras de liberación prolongada, ADVAGRAF 0,5 mg cápsulas duras de liberación prolongada
Dr. Antonio Román Broto
PACIENTES CON TRASPLANTE PULMONAR ESTABLE
 
 
2014-001372-66: Tacrolimus monotherapy for low risk kidney transplant recipients. Tacrolimus monotherapie bij laag-risico niertransplantatie patiënten.

Ongoing
2
100
Europe
Advagraf, CellCept, Advagraf, CellCept, Advagraf, CellCept
Erasmus Medical Center, Erasmus medical Center
kidney transplantation niertransplantatie
 
 
NCT00792948: Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

Active, not recruiting
2
97
US
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic, Allogeneic Hematopoietic Cell Transplantation, Allogeneic Stem Cell Transplantation, HSC, HSCT, Stem Cell Transplantation, Allogeneic, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B-518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, WR-138719, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-Cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Dasatinib, BMS-354825, Dasatinib Hydrate, Dasatinib Monohydrate, Sprycel, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Dxevo, Fluorodelta, Fortecortin, Gammacorten, Hemady, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin HCl, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, hydroxydaunorubicin, Rubex, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP 16213, VP-16, VP-16-213, VP16, Filgrastim, Filgrastim Biosimilar Filgrastim-sndz, Filgrastim Biosimilar Tbo-filgrastim, Filgrastim XM02, Filgrastim-aafi, Filgrastim-ayow, Filgrastim-sndz, G-CSF, Granix, Neupogen, Neutroval, Nivestym, r-metHuG-CSF, Recombinant Methionyl Human Granulocyte Colony Stimulating Factor, Releuko, rG-CSF, Tbo-filgrastim, Tevagrastim, XM02, Zarxio, Laboratory Biomarker Analysis, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Methylprednisolone, Adlone, Caberdelta M, DepMedalone, Depo Moderin, Depo-Nisolone, Duralone, Emmetipi, Esametone, Firmacort, Medlone 21, Medrate, Medrol, Medrol Veriderm, Medrone, Mega-Star, Meprolone, Methylprednisolonum, Metilbetasone Solubile, Metrocort, Metypresol, Metysolon, Predni-M-Tablinen, Prednilen, Radilem, Sieropresol, Solpredone, Summicort, Urbason, Veriderm Medrol, Wyacort, Peripheral Blood Stem Cell Transplantation, PBPC transplantation, PBSCT, Peripheral Blood, Peripheral Blood Progenitor Cell Transplantation, PERIPHERAL BLOOD STEM CELL TRANSPLANT, Peripheral Stem Cell Support, Peripheral Stem Cell Transplant, Peripheral Stem Cell Transplantation, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Sirolimus, AY 22989, RAPA, Rapamune, Rapamycin, SILA 9268A, WY-090217, Tacrolimus, FK 506, FK-506, Fujimycin, Hecoria, Prograf, Protopic, Tacforius, Total-Body Irradiation, SCT_TBI, TBI, Total Body Irradiation, Whole Body, Whole Body Irradiation, Whole-Body Irradiation, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Adult L1 Acute Lymphoblastic Leukemia, Adult L2 Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia
06/16
01/25
2019-003585-40: Tacrolimus for bleeding in hereditary hemorrhagic telangiectasia patients

Not yet recruiting
2
20
Europe
Tacrolimus (Advagraf), EMEA/H/C/000712, Capsule, Tacrolimus (Advagraf)
St. Antonius Hospital, ZonMW
Gastrointestinal bleeding and epistaxis caused by hereditary hemorrhagic telangiectasia. Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant inherited disease characterized by mucocutaneous telangiectasis. Telangiectasis predominantly observed in the nasal mucosa and gut, and are abnormal, thin walled blood vessel that can easily rupture leading to hemorrhage., A genetic disorder called Hereditary Hemorrhagic Telangiectasia, also known as Rendu-Osler-Weber syndrome, Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
 
 
NCT06128070: Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Not yet recruiting
2
40
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Chest Computed Tomography, Chest CT, Computed Tomography of the Chest, Echocardiography, EC, Hematopoietic Cell Transplantation, HCT, Hematopoietic Stem Cell Infusion, Hematopoietic Stem Cell Transplantation, HSCT, SCT, Stem Cell Transplant, stem cell transplantation, Stem Cell Transplantation, NOS, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Ruxolitinib Phosphate, INCB-18424 Phosphate, Jakafi, Jakavi, Tacrolimus, FK 506, FK-506, Fujimycin, Hecoria, Prograf, Protopic, Tacforius
City of Hope Medical Center, National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
10/27
10/27
NCT04370301: Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Recruiting
2
10
US
Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Asta B 518, B-518, WR-138719, JAK Inhibitor, JAK inhibitors, Janus Kinase Inhibitor, Ruxolitinib, Fedratinib, Fludarabine, Fluradosa, Recombinant Granulocyte Colony-Stimulating Factor, Recombinant Colony-Stimulating Factor 3, rhG-CSF, 143011-72-7, Melphalan, Alanine Nitrogen Mustard, CB-3025, L-PAM, L-Phenylalanine mustard, L-sarcolysin, L-Sarcolysin Phenylalanine mustard, L-Sarcolysine, Melphalanum, Phenylalanine Mustard, Phenylalanine Nitrogen Mustard, Sarcoclorin, Sarkolysin, WR-19813, Mycophenolate Mofetil, Cellcept, MMF, Peripheral Blood Stem Cell Transplantation, PBPC transplantation, PBSCT, Peripheral Blood Progenitor Cell Transplantation, peripheral stem cell support, Peripheral Stem Cell Transplant, peripheral stem cell transplantation, Tacrolimus, FK 506, Fujimycin, Hecoria, Prograf, Protopic, FK-506, Tacforius, Total-Body Irradiation, TBI, Total Body Irradiation, Whole Body Irradiation, Whole-Body Irradiation, Total-Body Irradiation Prior to Stem Cell Transplant, SCT_TBI, Computed Tomography, CAT Scan, Computed Axial Tomography, CT SCAN, Magnetic Resonance Imaging, MR Imaging, MRI, Bone Marrow Biopsy, Biopsy of Bone Marrow, Bone Marrow Aspiration, Biospecimen Collection, Biological Sample Collection, Echocardiography, EC, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning
Fred Hutchinson Cancer Center
Primary Myelofibrosis, Secondary Myelofibrosis
08/24
08/29
NCT00882895: Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Active, not recruiting
2
18
US
Stem cell infusion, TLI, Anti-thymocyte globulin, ATG, Atgam, Thymoglobulin, Solumedrol, Medrol, Solu-Medrol, Tacrolimus, FK-506, Prograf, Advagraf, Protopic, Mycophenolate mofetil, MMF, CellCept, Myfortic
Washington University School of Medicine
Lymphoma, Non-Hodgkin
06/28
06/28
NCI-2018-01788, NCT03670966: 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Suspended
1/2
30
US
Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10, At 211 MAb BC8-B10, APAMISTAMAB-B10-ASTATINE AT-211, Cyclophosphamide, (-)-Cyclophosphamide, Asta B 518, B-518, WR-138719, Total-Body Irradiation, Total Body Irradiation, SCT_TBI, Whole Body Irradiation, Whole-Body Irradiation, TBI, Peripheral Blood Stem Cell Transplantation, PBPC transplantation, Bone Marrow Transplantation, Bone Marrow Grafting, BMT, Mycophenolate Mofetil, 115007-34-6, MMF, Cellcept, Recombinant Granulocyte Colony-Stimulating Factor, 143011-72-7, Recombinant Colony-Stimulating Factor 3, rhG-CSF, Fludarabine Phosphate, 2-F-ara-AMP, Beneflur, Fludara, Fludarabine-5''-Monophosphate, SH T 586, Tacrolimus, Prograf, Protopic, FK 506, FK-506, Tacforius, Bone Marrow Aspiration and Biopsy, Biospecimen Collection, Biological Sample Collection
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome With Excess Blasts, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Refractory Mixed Phenotype Acute Leukemia, Hematopoietic and Lymphoid Cell Neoplasm
06/25
03/27
2008-001440-39: Estudio clinico intrapaciente de biodisponibilidad relativa de dos formulaciones de tacrolimus: Prograf (comprimidos de liberación normal) y Advagraf (comprimidos de liberación sostenida) en adolescentes (12-18 años) trasplantados de hígado.

Ongoing
1
20
Europe
Advagraf 0,5 mg, Advagraf 1 mg, Advagraf 5 mg, Advagraf 0,5 mg, Advagraf 1 mg, Advagraf 5 mg, Advagraf 0,5 mg, Advagraf 1 mg, Advagraf 5 mg
Asociación de Investigación Hepatológica y Transplante Hepático Infantil
Pacientes con transplante hepático de 12 a 18 años de edad, en situación clínica estable y con niveles estables de Tacrolimus.
 
 
2009-017600-89: Ensayo intrapaciente de biodisponibilidad relativa de dos formulaciones de tacrolimus: Prograf (comprimidos de liberación normal) y Advagraf (comprimidos de liberación sostenida) en niños trasplantados de riñón

Ongoing
1
20
Europe
ADVAGRAF 0,5 mg cápsulas duras de liberación prolongada, ADVAGRAF 1 mg cápsulas duras de liberación prolongada, ADVAGRAF 5 mg cápsulas duras de liberación prolongada, ADVAGRAF 3 mg cápsulas duras de liberación prolongada, PROGRAF 0,5 mg cápsulas duras, PROGRAF 5 mg cápsulas duras, PROGRAF 1 mg cápsulas duras, ADVAGRAF 0,5 mg cápsulas duras de liberación prolongada, ADVAGRAF 1 mg cápsulas duras de liberación prolongada, ADVAGRAF 5 mg cápsulas duras de liberación prolongada, ADVAGRAF 3 mg cápsulas duras de liberación prolongada, PROGRAF 0,5 mg cápsulas duras, PROGRAF 5 mg cápsulas duras, PROGRAF 1 mg cápsulas duras
Asociación para la investigación de Nefrología Infantil
Transplante renal
 
 
NCT01163357: Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Active, not recruiting
1
18
US
bortezomib, LDP 341, MLN341, PS-341, VELCADE, fludarabine phosphate, 2-F-ara-AMP, Beneflur, Fludara, melphalan, Alkeran, CB-3025, L-PAM, L-phenylalanine mustard, L-Sarcolysin, Melfalan, total marrow irradiation, tacrolimus, Advagraf, FK 506, Prograf, Protopic, sirolimus, AY 22989, RAPA, Rapamune, rapamycin, SILA 9268A, SLM, peripheral blood stem cell transplantation, PBPC transplantation, PBSC transplantation, peripheral blood progenitor cell transplantation, transplantation, peripheral blood stem cell, laboratory biomarker analysis
City of Hope Medical Center, National Cancer Institute (NCI)
Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
07/19
12/24
NCT03963505: Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.

Not yet recruiting
1
100
Europe
Advagraf®, Generic tacrolimus
Sandoz
Kidney Transplant
05/20
05/20
NCT03816332: Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

Active, not recruiting
1
12
US
Ipilimumab, Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody, BMS-734016, Ipilimumab Biosimilar CS1002, MDX-010, MDX-CTLA4, Yervoy, Nivolumab, ABP 206, BCD-263, BMS-936558, CMAB819, MDX-1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO-4538, Opdivo, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Tacrolimus, FK 506, FK-506, Fujimycin, Hecoria, Prograf, Protopic, Tacforius
National Cancer Institute (NCI)
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8, Metastatic Basal Cell Carcinoma, Metastatic Melanoma, Metastatic Merkel Cell Carcinoma, Metastatic Skin Squamous Cell Carcinoma, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage IIIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Pathologic Stage IV Cutaneous Melanoma AJCC v8, Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8, Unresectable Basal Cell Carcinoma, Unresectable Melanoma, Unresectable Merkel Cell Carcinoma
10/22
09/24
NCT02333162: Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

Recruiting
1
30
US
Fludarabine Phosphate, 2-F-ara-AMP, Beneflur, SH T 586, Melphalan, Alkeran, Intensity-Modulated Radiation Therapy, IMRT, Intensity Modulated RT, Intensity-Modulated Radiotherapy, Total Marrow Irradiation, Allogeneic Hematopoietic Stem Cell Transplantation, HSC, HSCT, Peripheral Blood Stem Cell Transplantation, PBPC transplantation, Peripheral Blood Progenitor Cell Transplantation, Peripheral Stem Cell Support, Peripheral Stem Cell Transplantation, Allogeneic Bone Marrow Transplantation, Allo BMT, Allogeneic BMT, Tacrolimus, Advagraf, FK 506, Mycophenolate Mofetil, Cellcept, MMF, Laboratory Biomarker Analysis
University of Chicago, National Cancer Institute (NCI)
Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Hematologic Malignancy
12/28
12/28
NCT05088356: Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

Recruiting
1
40
US
Purified regulatory T-cells (Treg) plus CD34+ HSPC, Fludarabine, Beneflur, SH T 586, fludarabine monophosphate, Melphalan, Melphalanum, CliniMACS CD34 Reagent System, Tacrolimus, Prograf, Advagraf, fujimycin, Cyclophosphamide, alkylating agent, Plerixafor, Mozobil, AMD 3100, LM-3100, Filgrastim granulocyte colony-stimulating factor (G-CSF) or equivalent, filgrastim XM02, Thiotepa, Tepandina, Mycophenolate Mofetil (MMF), CellCept, Ruxolitinib, Jakafi
Stanford University, Orca Biosystems, Inc.
Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders
12/25
12/25
NCT06287944: 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Not yet recruiting
1
15
US
Actinium Ac 225-DOTA-Daratumumab, 225Ac-DOTA-Daratumumab, [225Ac]-DOTA-Daratumumab, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Daratumumab, Daratumumab Biosimilar HLX15, Daratumumab-fihj, Darzalex, HLX15, HuMax-CD38, JNJ-54767414, Echocardiography, EC, Fludarabine, Fluradosa, Hematopoietic Cell Transplantation, HCT, Hematopoietic Stem Cell Infusion, Hematopoietic Stem Cell Transplantation, HSCT, SCT, Stem Cell Transplant, stem cell transplantation, Stem Cell Transplantation, NOS, Indium In 111-DOTA-Daratumumab, 111In-DOTA-Daratumumab, [111In]-DOTA-Daratumumab, Melphalan, Alanine Nitrogen Mustard, CB-3025, L-PAM, L-Phenylalanine Mustard, L-Sarcolysin, L-Sarcolysin Phenylalanine mustard, L-Sarcolysine, Melphalanum, Phenylalanine Mustard, Phenylalanine Nitrogen Mustard, Sarcoclorin, Sarkolysin, WR-19813, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Radionuclide Imaging, NM, Nuclear Medicine, nuclear medicine scan, radioimaging, Radionuclide Scanning, Scan, Scintigraphy, Single Photon Emission Computed Tomography, Medical Imaging, Single Photon Emission Computed Tomography, Single Photon Emission Tomography, Single-Photon Emission Computed, single-photon emission computed tomography, SPECT, SPECT imaging, SPECT SCAN, SPET, ST, tomography, emission computed, single photon, Tomography, Emission-Computed, Single-Photon, Sirolimus, AY 22989, RAPA, Rapamune, Rapamycin, SILA 9268A, WY-090217, Tacrolimus, FK 506, FK-506, Fujimycin, Hecoria, Prograf, Protopic, Tacforius, Total Marrow and Lymphoid Irradiation, TMLI
City of Hope Medical Center, National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
02/27
02/27
NCT06195891: Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Recruiting
1
33
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Dual-Energy Computed Tomography, DECT, Echocardiography, EC, Fludarabine, Fluradosa, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Melphalan, Alanine Nitrogen Mustard, CB-3025, L-PAM, L-Phenylalanine Mustard, L-Sarcolysin, L-Sarcolysin Phenylalanine mustard, L-Sarcolysine, Melphalanum, Phenylalanine Mustard, Phenylalanine Nitrogen Mustard, Sarcoclorin, Sarkolysin, WR-19813, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Partially Engineered T-regulatory Cell Donor Graft TRGFT-201, Orca-T, Partially Engineered and Enriched Treg Donor Graft TRGFT-201, T-cell-Depleted Graft With Additional Infusion of Conventional T Cells and Regulatory T Cells, TregGraft, TRGFT 201, TRGFT-201, TRGFT201, Tacrolimus, FK 506, FK-506, Fujimycin, Hecoria, Prograf, Protopic, Tacforius, Thiotepa, 1,1',1''-Phosphinothioylidynetrisaziridine, Girostan, N,N', N''-Triethylenethiophosphoramide, Oncotiotepa, STEPA, Tepadina, TESPA, Tespamin, Tespamine, Thio-Tepa, Thiofosfamide, Thiofozil, Thiophosphamide, Thiophosphoamide, Thiophosphoramide, Thiotef, Tifosyl, TIO TEF, Tio-tef, Triethylene Thiophosphoramide, Triethylenethiophosphoramide, Tris(1-aziridinyl)phosphine sulfide, TSPA, WR 45312, Total Marrow and Lymphoid Irradiation, TMLI
City of Hope Medical Center, National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
06/27
06/27
NCT00423826: Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

No Longer Available
N/A
US
Busulfan, Busulfex®, Myleran®, Cytarabine, DepoCyt(TM), Liposomal Ara-C, Fludarabine phosphate, Fludara, mycophenolate mofetil, Cellcept, tacrolimus, Advagraf, Prograf, Protopic, allogeneic hematopoietic stem cell transplantation, umbilical cord blood transplantation, total-body irradiation
Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis
01/15
01/15
OnceDaily, NCT02426502: Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients

Active, not recruiting
N/A
76
Canada
Conversion to Advagraf, Prograf, Cyclosporine (Neoral), Advagraf, conversion of non-immunosuppressant drugs to once daily, anti-hypertensive medications, non-immunosuppressant drugs, Conversion to once daily MPA, Mycophenolate Mofetil, Myfortic, Azathioprine, Prednisone
University of British Columbia, Astellas Pharma Canada, Inc.
End-Stage Renal Disease
08/22
12/24
FreeTAC, NCT04657562: The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma

Recruiting
N/A
380
Europe
Tacrolimus, Prograf, Advagraf, Unbound tacrolimus measurement, CYP3A4 and CYP3A5 genotyping
National Science Centre, Poland, Medical University of Warsaw
Immunosuppression, Kidney Transplant Rejection, Kidney Transplant; Complications, Liver Transplant Rejection, Liver Transplant; Complications, Metabolism Medication Toxicity, Genetic Predisposition
12/22
05/23
NCT06183892: Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant Recipients

Not yet recruiting
N/A
80
RoW
Tacrolimus Sustained-release Capsules
RenJi Hospital
Liver Transplant
07/25
07/26
SENIOR, NCT02558452 / 2013-000450-22: European Transplant Registry of Senior Renal Transplant Recipients on Advagraf

Not yet recruiting
N/A
1000
Europe
Tacrolimus once daily (Advagraf), mycophenolate, steroids
Klemens Budde, Dr. med. univ. L. J. Lehner, Charite University, Berlin, Germany, ERA-EDTA, DESCARTES Working Group On Transplantation, European Kidney Transplant Association (EKITA)
Graft Failure, Death, Acute Rejection of Renal Transplant, Infections, Bone Disease, Post Transplant Diabetes Mellitus, Quality of Life, HLA Antibody Production, Cardiovascular Risk Factors, Non-HLA Antibody Production
01/27
01/28

Download Options